Wellteq Digital Health - Chairman, Dr. Peter Vaughan
Chairman, Dr. Peter Vaughan
Source: LinkedIn
  • Wellteq (WTEQ) Chairman Dr. Peter Vaughan has been appointed to the Order of Canada by the Governor General of Canada
  • Dr. Vaughan was cited for his contributions to Canada’s health care system and leadership in the advancement of digital health
  • Dr. Vaughan was appointed Chairman of the Board of Directors for Wellteq just prior to the company’s listing on the Canadian Securities Exchange
  • Wellteq is a leading global provider of personalized digital health and wellness solutions
  • Wellteq Digital Health Inc. (WTEQ) opened trading at C$0.065 per share

Wellteq (WTEQ) Chairman Dr. Peter Vaughan has been appointed to the Order of Canada by the Governor-General of Canada.

The Governor-General cited the appointment of Dr. Vaughan “for his contributions to Canada’s health care system, and for his pioneering leadership in the establishment and advancement of digital health”.

Dr. Vaughan, whose career spans medicine, public healthcare, academia and multiple board and executive positions is recognized for his tenacious evangelism of healthcare modernization.

Dr. Vaughan was appointed Chairman of the Board of Directors for Wellteq just prior to the company’s listing on the Canadian Securities Exchange in March 2021 and continues to lead the company’s execution to modernize healthcare delivery through the deployment of the Wellteq platform.

Wellteq is a leading global provider of personalized digital health and wellness solutions.

Wellteq Digital Health Inc. (WTEQ) opened trading at C$0.065 per share.

More From The Market Online

BlackBerry expands AI-powered cybersecurity service

BlackBerry (TSX:BB) releases the new and expanded CylanceMDR, a managed detection and response tool backed by its Cylance AI platform.

Qualcomm stock jumps on Q2 2024 earnings

Qualcomm (NDAQ:QCOM) shares rise nearly 10 per cent early Thursday on better-than-expected adjusted earnings and strong revenue guidance.

Cancer-fighting pharma stock eyes 2027 regulatory approval

Theralase Technologies (TSXV:TLT), a cancer-fighting pharma stock, expands its team with two clinical research associates.

Fobi AI could address a market in the trillions: Why it’s time to buy

Fobi AI (TSXV:FOBI) is an essential stock to consider to capitalize on the exponential trends of digital wallets and artificial intelligence.